Skip to main content
University of Washington School of Medicine Logo Genome Sciences

Faculty

Raymond Monnat

Research:

We are interested in the molecular mechanisms that insure human genome stability, and how these modulate cancer or other acquired disease risk, and the response to therapies such as anti-cancer chemo- and radiation therapies. We also develop and use genome engineering tools and approaches to understand, treat or prevent disease, and to determine the functional phenotype of human genetic variants.

Specific disease interests include the RECQ helicase and Fanconi anemia deficiency syndromes and associated cancers. Our more engineering-oriented work is focused on human gene therapy ‘safe harbor’ sites, preclinical models of human brain cancers such as glioblastoma and the use of gene drive technology to counter malaria.
More information on these research areas can be found on our lab website – follow the link from this page or search monnatlab.org

Selected Publications:

Knijnenburg, T, Wang, L, Chambwe, N …Monnat, R.J., Jr., Xiao, Y. and Wang, C. on behalf of TCGA DNA Damage Repair Analysis Working Group (2018) Landscape of DNA damage repair deficiency across The Cancer Genome Atlas. Cell Reports 23: 239-254. doi: 10.1016/j.celrep.2018.03.076.

Pellenz S, Phelps MP, Tang W, Hovde BT, Sinit R, Fu W, Li H, Chen E, and Monnat RJ Jr. (2019) New human chromosomal safe harbor sites for genome engineering with CRISPER/Cas9, TAL effector and homing endonucleases.  Human Gene Therapy 30:814-828. doi: 10.1089/hum.2018.16doi: 10.1089/hum.2018.169.

Horowitz L. F., Rodriguez A.D., Dereli-Korkut Z., Lin R., Castro K., Mikheev A., Monnat R.J. Jr., Folch A. and Rostomily R.C. (2020) Multiplexed drug testing of tumor slices using a microfluidic platform NPJ Precision Oncology 19;4:12. PMC7237421. doi: 10.1038/s41698-020-0117-y.

Hasle N, Cooke A, Srivatsan S, Huang H, Stephany JJ, Krieger Z, Jackson D, Tang Weilliang, Pendyala S, Monnat RJ Jr., Trapnell C, Hatch EM, and Fowler DM (2020). High-throughput microscope-based sorting to dissect cellular heterogeneity. Molecular Systems Biology 16(6):e9442. PMC7273721 DOI: 10.15252/msb.20209442.

Carbone M, Arron ST, Beutler B, Bononi A, Cavenee W, Cleaver JE, Croce CM, D’Andrea A, Foulkes WD, Gaudino G, Groden JL, Henske EP, Hickson ID, Hwang PM, Kolodner RD, Mak TW, Malkin D, Monnat RJ Jr, Novelli F, Pass HI, Petrini JH, Schmidt LS, Yang H. (2020) Tumour predisposition and cancer syndromes as models to study gene-environment interactions. Nature Reviews Cancer PMID: 32472073 DOI: 10.1038/s41568-020-0265-y.

Maynard Olson

Research:

New methods of genome analysis and the application of these methods to the study of the human and other genomes are the main focuses of our research, much of which is carried out at the University of Washington Genome Center. A major scientific focus of the Center’s research program involves the study of natural variation in DNA sequences. In human DNA, most of the variation involves simple base-pair substitution polymorphisms: typical humans are heterozygous at approximately one base pair in a thousand throughout most of the genome. However, there are some regions in which sequence variation is as high as several percent of the nucleotides. We are developing new methods to detect these “variation hot spots” and to analyze the evolutionary forces that gave rise to them.

In parallel with the human studies, we are analyzing genetic variation in the opportunistic human pathogen Pseudomonas aeruginosa. The Genome Center recently determined the sequence of the 6.3-Mbp genome of this bacterium and is now analyzing variation in the genome across different clinical isolates of P. aeruginosa and across time during chronic infections of individual patients. In this research, our principal focus is on pulmonary infections of cystic fibrosis patients. The airways of most CF patients become infected with P. aeruginosa, and these infections now account for most of the morbidity and mortality in CF.

Selected Publications:

Stover, C.K., Pham, X.Q., Erwin, A.L., Mizoguchi, S.D., Warrener, P., Hickey, M.J., Brinkman, F.S.L., Hufnagle, W.O., Kowalik, D.J., Lagrou, M., Garber, R.L., Goltry, L., Tolentino, E., Westbrock-Wadman, S., Yuan, Y., Brody, L.L., Coulter, S.N., Folger, K.R., Kas, A., Larbig, K., Lim, R., Smith, K., Spencer, D., Wong, G.K.-S., Wu, Z., Paulsen, I.T., Reizer, J., Saier, M.H., Hancock, R.E.W., Lory, S., and Olson, M.V. (2000). Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406: 959-964.

Wood, D.W., Setubal, J.C., Kaul, R., Monks, D.E., Kitajima, J.P., Okura, V.K., Zhou, Y., Chen, L., Wood, G.E., Almeida Jr., N.F., Woo, L., Chen, Y., Paulsen, I.T., Eisen, J.A., Karp, P.D., Bovee Sr., D., Chapman, P., Clendenning, J., Deatherage, G., Gillett, W., Grant, C., Kutyavin, T., Levy, R., Li, M.-J., McClelland, E., Palmieri, A., Raymond, C., Rouse, P., Saenphimmachak, C., Wu, Z., Romero, P., Gordon, D., Zhang, S., Yoo, H., Tao, Y., Biddle, P., Jung, M., Krespan, W., Perry, M., Gordon-Kamm, B., Liao, L., Kim, S., Henrick, C., Zhao, Z.-Y., Dolan, M., Chumley, F., Tingey, S.V., Tomb, J.-F., Gordon, M.P., Olson, M.V., and Nester, E.W. (2001). The genome of the natural genetic engineer Agrobacterium tumefaciens C58. Science 294, 2317-2323.

International Human Genome Sequencing Consortium (2001). Initial sequencing and analysis of the human genome. Nature 409: 860-921.

Raymond, C.K., Sims, E.H., and Olson, M.V. (2002). Linker-mediated recombinational subcloning of large DNA fragments using yeast. Genome Res. 12, 190-197.

Raymond, C.K., Sims, E.H., Kas, A., Spencer, D.H., Kutyavin, T.V., Ivey, R.G., Zhou, Y., Kaul, R., Clendenning, J.B., and Olson, M.V. (2002). Genetic variation at the O-antigen biosynthetic lcus in Pseudomonas aeruginosa. J. Bacteriol. 184, 3614-3622.

Williams, B.J., Golomb, M., Phillips, T., Brownlee, J., Olson, M.V., and Smith, A.L. (2002). Bacteriophage HP2 of Haemophilus influenzae. J. Bacteriol. 184, 6893-6905.

Olson, M.V. (2002). The Human Genome Project: A player?s perspective. J. Mol Biol. 319, 931-942.

Spencer, D.H., Kas, A., Smith, E.E., Raymond, C.K., Sims, E.H., Hastings, M., Burns, J.L., Kaul, R., and Olson M.V. (2003). Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J. Bacteriol. 185, 1316-1325.

Jacobs, M.A., Alwood, A., Thaipisuttikul, I., Spencer, D., Haugen, E., Ernst, S., Will, O., Kaul, R., Raymond, C., Levy, R., Chun-Rong, L., Guenthner, D., Bovee, D., Olson, M.V., and Manoil, C. (2003). Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA, 100, 14339-14344.

Olson, M.V., Kas, A., Bubb, K., Qui, R., Smith, E.E., Raymond, C.K., and Kaul, R. (2004). Hypervariability, suppressed recombination and the genetics of individuality. Phil. Trans. R. Soc. London, Series B 359, 129-140.

additional publication listings available via PubMed

Carol Sibley

Research:

Plasmodium falciparum is a single celled parasite that causes the most deadly of the 4 kinds of human malaria. There is currently no vaccine to prevent this disease, and about 200 million people suffer from malaria each year. In fact, malaria causes 2 million deaths each year, most of them children in sub-Saharan Africa. There is an acute need for effective chemotherapeutic agents for prophylaxis and treatment of falciparum malaria. Drugs that target dihydrofolate reductase (DHFR), a key enzyme in the synthesis of deoxythymidine, histidine, and methionine and sulfonamides that target dihydropteroate synthase (DHPS), required for the synthesis of folate have been extremely effective in the past . In most cases, combinations of these drugs have been used, because the drugs act synergistically. However, the incredibly rapid selection of resistant P. falciparum populations has made the drugs virtually useless in many regions. The parasites are resistant to the drugs because they carry alleles of the DHFR or DHPS genes that encode mutant forms of the target enzyme.

The P. falciparum parasites can be grown in the lab, but their culture is expensive and labor intensive. To simplify study of these target enzymes from P. falciparum, we have engineered a series of strains of the budding yeast, Saccharomyces cerevisiae. These yeast lack endogenous DHFR or DHPS, but can grow because we have transformed them with the P. falciparum version of one of these enzymes. This approach has allowed us to use the yeast system to study the function of the parasite enzymes in a simple, inexpensive way. Normally, yeast are insensitive to antimalaria drugs, but these engineered yeast strains are now sensitive to inhibitors of the P. falciparum enzymes. We are studying the mutations in the DHFR and DHPS genes that confer resistance to inhibitors of these enzymes. We have used this approach to identify new mutations that can encode drug-resistant enzymes, and to screen a panel of potential new inhibitors for their effectiveness against the parasite enzymes. In addition, we have used the polymerase chain reaction to amplify DHFR genes from blood samples collected between 1984 and 2001 in Kenya. Yeast strains that express these alleles have been engineered, and used to characterize the drug sensitivity profiles of the parasites that infected these patients. These data are being used to reconstruct the history of the selection for drug-resistant alleles that has occurred since the introduction of Fansidar into use in Kenya.

We have recently extend these studies to include the DHFR and DHPS genes from a number of other related pathogens (Plasmodium vivax, Cryptosporidium parvum, Toxoplasma gondii)  and the bacterium that causes tuberculosis, Mycobacterium tuberculosis. We have two overall goals in our work. First, to use the basic techniques of genetics and molecular biology to understand the mechanism of inhibition of DHFR and DHPS by antifolate drugs. This will allow the design of alternative drugs that are effective against parasites that are resistant to currently available drugs. Second, to use this simple yeast system to understand the selection pressures that have resulted in mutations that confer drug resistance.  Our work is highly collaborative.  We have strong collaborations with colleagues at the Wellcome Trust Research Laboratory in Nairobi, Kenya, the National Institute for Medical Research, Amani-Tanga, Tanzania, the Liverpool School of Tropical Medicine, the London School of Hygiene and Tropical Medicine, and the University of Manchester Institute of Science and Technology, in the UK, Jacobus Pharmaceutical Company in Princeton, NJ, the Dana Farber Cancer Institute, Boston, MA and the CSIRO in Melbourne, Australia. We hope to apply our  understanding of antifolate drugs to design deployment and use strategies that will slow the selection of drug-resistant parasites in the future.

Selected Publications:

Certain, L and Sibley, CH. 2007. Plasmodium falciparum: A novel method for analyzing haplotypes in mixed infections. Experimental Parasutology, 115:233-241.

Sandefur, CI, Wooden, JM, Quaye, IK, Sirawaraporn, W and Sibley, CH . 2007. Pyrimethamine-resistant dihydrofolate reductase enzymes of P. falciparum are not enzymatically compromised in vitro. Molecular and Biochemical Parasitology.154:1-5.

VN Hawkins, H Joshi, K Rungsihirunrat, K Na-Bangchang, CH Sibley: 2007 Antifolates can have a role in the treatment of Plasmodium vivax. Trends Parasitol 23: 213-222.

Sibley CH, Barnes KI and Plowe CV .2007. The rationale and plan for creating a World Antimalarial Resistance Drug Network (WARN). Malar J 6:118.

Price RN, Dorsey G, Ashley EA, Barnes KI, Baird JK, d’Alessandro U, Guerin PJ, Laufer MK, Naidoo I, Nosten F, Olliaro P, Plowe CV, Ringwald P, Sibley CH, Stepniewska K and White NJ .2007. World Antimalarial Resistance Network (WARN) I: Clinical efficacy of antimalarial therapy. Malar J 6:119.

Plowe CV, Roper C, Barnwell JW, Happi CT, Joshi HH, Mbacham W, Meshnick SR, Mugittu K, Naidoo I, Price RN, Shafer RW, Sibley CH, Sutherland CJ, Zimmerman PA and Rosenthal PJ. 2007. World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria. Malar J 6:121.

Bacon DJ, Jambou R, Fandeur T, Le Bras J, Wongsrichchanalai C, Fukuda MM, Ringwald P, Sibley CH and Kyle DE. 2007. World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility. Malar J 6:120.

Barnes KI, Lindegardh N, Ogundahunsi O, Olliaro P, Plowe CV, Randrianarivelojosia M, Gbotosho GO, Watkins WM, Sibley CH and White NJ. 2007. World Antimalarial Resistance Network (WARN) IV: Clinical pharmacology. Malar J 6:122.

additional publication listings available via PubMed

Barbara Trask

Research:

The Trask group studies large-scale facets of genome organization. Our work relies on continued development of fluorescence in situ hybridization (FISH), a means of fluorescently tagging specific DNA sequences in chromosomes or nuclei, and flow cytometry, a technology for isolating specific chromosomes for molecular analyses based on their DNA content.

One aspect of genomic organization under study is the arrangement of DNA within the interphase nucleus. Two meters of DNA are packed within each nucleus in interphase, the stage when transcription, repair, and replication occur. FISH is used to mark sites of sequences lying at known distances from each other on the same chromosome (or on different chromosomes). By comparing interphase distances between these points to predictions of various physical models, such as that of a random-walk, we hope to learn which arrangements, if any, are dictated by functional constraints and which can be explained by the physical forces acting on these large molecules.

The structure, function, and evolution of some of the more complex and variable regions of the human genome are also under investigation. One project focuses on the subtelomeric regions of human chromosomes. These regions are a patchwork of sequence-blocks that are duplicated near the ends of multiple chromosomes. They exhibit remarkable polymorphism: the number and location of large blocks can vary among individuals. Because these segments can contain genes, the compositional variability of subtelomeric DNA may have phenotypic consequences. A combination of molecular and cytogenetic techniques is currently being used to unravel the structure and function of these highly dynamic regions of the genome.

In addition, we are studying the large and complex duplications encompassing members of the olfactory receptor gene family. Members of this large gene family are distributed over 40 sites in the human genome, yet each sensory neuron expresses only one gene. In order to determine how the expressed repertoire of olfactory receptors has evolved and is regulated, we are analyzing the genomic organization and function of these genes in mouse and man.

Selected Publications:

McPherson JD, Marra M, Hillier L, Waterston RH, Chinwalla A, Wallis  J, Sekhon M, Wylie K, Mardis ER, Wilson RK, Fulton R, Kucaba TA,  Wagner-McPherson C, Barbazuk WB, Gregory SG, Humphray SJ, French L,  Evans RS, Bethel G, Whittaker A, Holden JL, McCann OT, Dunham A,  Soderlund C, Scott CE, Bentley DR, Schuler G, Chen HC, Jang W, Green  ED, Idol JR, Maduro VV, Montgomery KT, Lee E, Miller A, Emerling S,  Kucherlapati, Gibbs R, Scherer S, Gorrell JH, Sodergren E, Clerc- Blankenburg K, Tabor P, Naylor S, Garcia D, de Jong PJ, Catanese JJ,  Nowak N, Osoegawa K, Qin S, Rowen L, Madan A, Dors M, Hood L, Trask  B, Friedman C, Massa H, Cheung VG, Kirsch IR, Reid T, Yonescu R,  Weissenbach J, Bruls T, Heilig R, Branscomb E, Olsen A, Doggett N,  Cheng JF, Hawkins T, Myers RM, Shang J, Ramirez L, Schmutz J,  Velasquez O, Dixon K, Stone NE, Cox DR, Haussler D, Kent WJ, Furey T,  Rogic S, Kennedy S, Jones S, Rosenthal A, Wen G, Schilhabel M,  Gloeckner G, Nyakatura G, Siebert R, Schlegelberger B, Korenberg J,  Chen XN, Fujiyama A, Hattori M, Toyoda A, Yada T, Park HS, Sakaki Y,  Shimizu N, Asakawa S, Kawasaki K, Sasaki T, Shintani A, Shimizu A,  Shibuya K, Kudoh J, Minoshima S, Ramser J, Seranski P, Hoff C,  Poustka A, Reinhardt R, Lehrach H. A physical map of the human  genome. Nature 409:934-941, 2001.

Olivier M, Aggarwal A, Allen J, Almendras AA, Bajorek ES, Beasley EM,  Brady SD, Bushard JM, Bustos VI, Chu A, Chung TR, De Witte A, Denys  ME, Dominguez R, Fang NY, Foster BD, Freudenberg RW, Hadley D,  Hamilton LR, Jeffrey TJ, Kelly L, Lazzeroni L, Levy MR, Lewis SC, Liu  X, Lopez FJ, Louie B, Marquis JP, Martinez RA, Matsuura MK, Misherghi  NS, Norton JA, Olshen A, Perkins SM, Perou AJ, Piercy C, Piercy M,  Qin F, Reif T, Sheppard K, Shokoohi V, Smick GA, Sun WL, Stewart EA,  Fernando J, Tejeda, Tran NM, Trejo T, Vo NT, Yan SC, Zierten DL, Zhao  S, Sachidanandam R, Trask BJ, Myers RM, Cox DR. A high-resolution  radiation hybrid map of the human genome draft sequence. Science  291:1298-1302, 2001.

Bailey JA, Yavor AM, Massa HF, Trask BJ, Eichler EE. Segmental  duplications: organization and impact within the current human genome  project assembly. Genome Res 11:1005-1017, 2001.

Kouros-Mehr H, Pintchovski S, Melnyk J, Chen YJ, Friedman C, Trask B,  Shizuya H. Identification of non-functional human VNO receptor genes  provides evidence for vestigiality of the human VNO. Chem Senses  26:1167-1174, 2001.

Lane RP, Roach JC, Lee IY, Boysen C, Smit A, Trask BJ, Hood L.  Genomic analysis of the olfactory receptor region of the mouse and  human T-cell receptor alpha/delta loci. Genome Res 12:81-87, 2002.

Lane RP, Cutforth T, Axel R, Hood L, Trask BJ. Sequence analysis of  mouse vomeronasal receptor gene clusters reveals common promoter  motifs and a history of recent expansion. Proc Natl Acad Sci U S A  99:291-296, 2002.

Young JM, Friedman C, Williams EM, Ross JA, Tonnes-Priddy L, Trask  BJ. Different evolutionary processes shaped the mouse and human  olfactory receptor gene families. Hum Mol Genet 11:535-546, 2002.

Mefford HC, Trask BJ. The complex structure and dynamic evolution of  human subtelomeres. Nat Rev Genet 3:91-102, 2002.

Gygi MP, Ferguson MD, Mefford HC, Lund KP, O’Day C, Zhou P, Friedman  C, van den Engh G, Stolowitz ML, Trask BJ. Use of fluorescent  sequence-specific polyamides to discriminate human chromosomes by  microscopy and flow cytometry. Nucleic Acids Res 30:2790-2799, 2002.

Tanaka H, Tapscott SJ, Trask BJ, Yao MC. Short inverted repeats  initiate gene amplification through the formation of a large DNA  palindrome in mammalian cells. Proc Natl Acad Sci U S A 99:8772-8777,  2002.

Sultana R, Yu CE, Yu J, Munson J, Chen D, Hua W, Estes A, Cortes F,  de la Barra F, Yu D, Haider ST, Trask BJ, Green ED, Raskind WH,  Disteche CM, Wijsman E, Dawson G, Storm DR, Schellenberg GD,  Villacres EC. Identification of a novel gene on chromosome 7q11.2  interrupted by a translocation breakpoint in a pair of autistic  twins. Genomics 80:129-134, 2002.

Trask BJ. Human cytogenetics: 46 chromosomes, 46 years and counting.  Nat Rev Genet 3:769-778, 2002.

Fan Y, Linardopoulou E, Friedman C, Williams E, Trask BJ. Genomic  structure and evolution of the ancestral chromosome fusion site in  2q13-2q14.1 and paralogous regions on other human chromosomes. Genome  Res 12:1651-1662, 2002.

Fan Y, Newman T, Linardopoulou E, Trask BJ. Gene content and function  of the ancestral chromosome fusion site in human chromosome  2q13-2q14.1 and paralogous regions. Genome Res 12:1663-1672, 2002.

Newman T, Trask BJ. Complex evolution of 7E olfactory receptor genes  in segmental duplications. Genome Res 13:781-793, 2003.

Heilig R, Eckenberg R, Petit JL, Fonknechten N, Da Silva C, Cattolico  L, Levy M, Barbe V, de Berardinis V, Ureta-Vidal A, Pelletier E, Vico  V, Anthouard V, Rowen L, Madan A, Qin S, Sun H, Du H, Pepin K,  Artiguenave F, Robert C, Cruaud C, Bruls T, Jaillon O, Friedlander L,  Samson G, Brottier P, Cure S, Segurens B, Aniere F, Samain S,  Crespeau H, Abbasi N, Aiach N, Boscus D, Dickhoff R, Dors M, Dubois  I, Friedman C, Gouyvenoux M, James R, Mairey-Estrada B, Mangenot S,  Martins N, Menard M, Oztas S, Ratcliffe A, Shaffer T, Trask B,  Vacherie B, Bellemere C, Belser C, Besnard-Gonnet M, Bartol-Mavel D,  Boutard M, Briez-Silla S, Combette S, Dufosse-Laurent V, Ferron C,  Lechaplais C, Louesse C, Muselet D, Magdelenat G, Pateau E, Petit E,  Sirvain-Trukniewicz P, Trybou A, Vega-Czarny N, Bataille E, Bluet E,  Bordelais I, Dubois M, Dumont C, Guerin T, Haffray S, Hammadi R,  Muanga J, Pellouin V, Robert D, Wunderle E, Gauguet G, Roy A, Sainte- Marthe L, Verdier J, Verdier-Discala C, Hillier L, Fulton L,  McPherson J, Matsuda F, Wilson R, Scarpelli C, Gyapay G, Wincker P,  Saurin W, Quetier F, Waterston R, Hood L, Weissenbach J. The DNA  sequence and analysis of human chromosome 14. Nature 421:601-607, 2003.

Young JM, Shykind BM, Lane RP, Tonnes-Priddy L, Ross JA, Walker M,  Williams EM, Trask BJ. Odorant receptor expressed sequence tags  demonstrate olfactory expression of over 400 genes, extensive  alternate splicing and unequal expression levels. Genome Biol 4:R71,  2003.

Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, Scherer  S, Scott G, Steffen D, Worley KC, Burch PE, Okwuonu G, Hines S, Lewis  L, DeRamo C, Delgado O, Dugan-Rocha S, Miner G, Morgan M, Hawes A,  Gill R, Celera, Holt RA, Adams MD, Amanatides PG, Baden-Tillson H,  Barnstead M, Chin S, Evans CA, Ferriera S, Fosler C, Glodek A, Gu Z,  Jennings D, Kraft CL, Nguyen T, Pfannkoch CM, Sitter C, Sutton GG,  Venter JC, Woodage T, Smith D, Lee HM, Gustafson E, Cahill P, Kana A,  Doucette-Stamm L, Weinstock K, Fechtel K, Weiss RB, Dunn DM, Green  ED, Blakesley RW, Bouffard GG, De Jong PJ, Osoegawa K, Zhu B, Marra  M, Schein J, Bosdet I, Fjell C, Jones S, Krzywinski M, Mathewson C,  Siddiqui A, Wye N, McPherson J, Zhao S, Fraser CM, Shetty J, Shatsman  S, Geer K, Chen Y, Abramzon S, Nierman WC, Havlak PH, Chen R, Durbin  KJ, Egan A, Ren Y, Song XZ, Li B, Liu Y, Qin X, Cawley S, Worley KC,  Cooney AJ, D’Souza LM, Martin K, Wu JQ, Gonzalez-Garay ML, Jackson  AR, Kalafus KJ, McLeod MP, Milosavljevic A, Virk D, Volkov A, Wheeler  DA, Zhang Z, Bailey JA, Eichler EE, Tuzun E, Birney E, Mongin E,  Ureta-Vidal A, Woodwark C, Zdobnov E, Bork P, Suyama M, Torrents D,  Alexandersson M, Trask BJ, Young JM, Huang H, Wang H, Xing H, Daniels  S, Gietzen D, Schmidt J, Stevens K, Vitt U, Wingrove J, Camara F, Mar  Alba M, Abril JF, Guigo R, Smit A, Dubchak I, Rubin EM, Couronne O,  Poliakov A, Hubner N, Ganten D, Goesele C, Hummel O, Kreitler T, Lee  YA, Monti J, Schulz H, Zimdahl H, Himmelbauer H, Lehrach H, Jacob HJ,  Bromberg S, Gullings-Handley J, Jensen-Seaman MI, Kwitek AE, Lazar J,  Pasko D, Tonellato PJ, Twigger S, Ponting CP, Duarte JM, Rice S,  Goodstadt L, Beatson SA, Emes RD, Winter EE, Webber C, Brandt P,  Nyakatura G, Adetobi M, Chiaromonte F, Elnitski L, Eswara P, Hardison  RC, Hou M, Kolbe D, Makova K, Miller W, Nekrutenko A, Riemer C,  Schwartz S, Taylor J, Yang S, Zhang Y, Lindpaintner K, Andrews TD,  Caccamo M, Clamp M, Clarke L, Curwen V, Durbin R, Eyras E, Searle SM,  Cooper GM, Batzoglou S, Brudno M, Sidow A, Stone EA, Venter JC,  Payseur BA, Bourque G, Lopez-Otin C, Puente XS, Chakrabarti K,  Chatterji S, Dewey C, Pachter L, Bray N, Yap VB, Caspi A, Tesler G,  Pevzner PA, Haussler D, Roskin KM, Baertsch R, Clawson H, Furey TS,  Hinrichs AS, Karolchik D, Kent WJ, Rosenbloom KR, Trumbower H,  Weirauch M, Cooper DN, Stenson PD, Ma B, Brent M, Arumugam M,  Shteynberg D, Copley RR, Taylor MS, Riethman H, Mudunuri U, Peterson  J, Guyer M, Felsenfeld A, Old S, Mockrin S, Collins F.  Genome  sequence of the Brown Norway rat yields insights into mammalian  evolution. Nature 428:493-521, 2004.

Lane RP, Young J, Newman T, Trask BJ. Species specificity in rodent  pheromone receptor repertoires. Genome Res 14:603-608, 2004.

Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, Maner S,  Massa H, Walker M, Chi M, Navin N, Lucito R, Healy J, Hicks J, Ye K,  Reiner A, Gilliam TC, Trask B, Patterson N, Zetterberg A, Wigler M.  Large-scale copy number polymorphism in the human genome. Science  305:525-528, 2004.

Loo LW, Grove DI, Williams EM, Neal CL, Cousens LA, Schubert EL,  Holcomb IN, Massa HF, Glogovac J, Li CI, Malone KE, Daling JR, Delrow  JJ, Trask BJ, Hsu L, Porter PL. Array comparative genomic  hybridization analysis of genomic alterations in breast cancer  subtypes. Cancer Res 64:8541-8549, 2004.

Young JM, Kambere M, Trask BJ, Lane RP. Divergent V1R repertoires in  five species: Amplification in rodents, decimation in primates, and a  surprisingly small repertoire in dogs. Genome Res 15:231-240, 2005.

Rowen L, Williams E, Glusman G, Linardopoulou E, Friedman C, Ahearn  ME, Seto J, Boysen C, Qin S, Wang K, Kaur A, Bloom S, Hood L, Trask  BJ. Interchromosomal segmental duplications explain the unusual  structure of PRSS3, the gene for an inhibitor-resistant trypsinogen.  Mol Biol Evol 22:1712-1720, 2005.

Linardopoulou EV, Williams EM, Fan Y, Friedman C, Young JM, Trask  BJ.  Human subtelomeres are hot spots of interchromosomal  recombination and segmental duplication.  Nature 437:94-100, 2005.

additional publication listings available via PubMed

Robert Waterston

Research:

With the increasing number of available complete genome sequences, the challenge shifts to understanding how the stored information is interpreted to enable life. We are exploring ways to contribute to the understanding of two of these genomes, those of the human and the nematode worm, C. elegans.

C. elegans offers unique advantages in understanding the regulatory circuitry that underpins development. The ability to follow the invariant pattern of cell divisions in real time offers an opportunity to describe gene expression patterns at an exceptional level of detail in time and space. To exploit this property, we are seeking to automate the determination of the lineage, and in turn overlay any pattern of gene expression on the lineage pattern. As a first step we have created GFP-histone fusion genes to label the nuclei and have used 4-d microscopy to record the full development of the animal. We are now developing computer programs to detect cell divisions and thereby reconstruct the cell lineage. Aided by comparative genome analysis we have also begun to create promoter-GFP fusions for a series of test genes to be introduced into the GFP-histone background to document patterns of gene expression. Initial efforts will be directed toward known transcription factors and in turn building up a likely network of interactions.

For the human genome, we are using comparative sequence analysis, first with mouse and currently with chimpanzee, to explore the ways comparative analysis can illuminate the function of the human genome. Longer term, we hope to be able use human polymorphism to aid in the assignment of likely gene function.

Selected Publications:

Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, et al.: Initial sequencing and analysis of the mouse genome. Nature 2002; 420(6915): 560-562.

International Human Genome Sequencing Consortium: Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.

The International Human Genome Mapping Consortium: A physical map of the human genome. Nature 2001; 409(6822): 934-941.

The International SNP Map Working Group: A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409: 928-933.

The C. elegans Sequencing Consortium: Genome sequence of the nematode C. elegans: A platform for investigating biology. Science 1998; 282: 2012-2018.

additional publication listings available via PubMed

Celeste Berg

Research:

Research in Celeste’s lab focuses on questions concerning patterning and shape — how individual cells within a sheet become different from each other and how they then work together to create an organ. These processes are important for the normal development of an organism, and it is these processes that are modulated to create new forms. To investigate patterning and shape, we use the model system Drosophila melanogaster, which has outstanding genetic and genomic tools that allow temporal and spatial manipulation of gene activity within individual cells. Genome sequence data from related Drosophila species and several distant insects facilitate identification of evolutionarily important sequences, and this information is coupled to a vast literature on these species’ adaptive morphological traits. Celeste has developed a culture system that allows live imaging of developmental events; this tool enables investigation of the mechanisms that execute development and that alter pattern and shape to create evolutionarily diverse forms. Understanding how pattern and shape create form is important because imperfections in these processes cause defects that affect an estimated 3% of live births. For more information on these processes, see the Berg Lab web page.

Selected Publications:

Berg, C., Sieber, M., and Sun, J. 2024. Finishing the egg. Genetics 226: iyad183. https://doi.org/10.1093/genetics/iyad183 PMCID: 10763546 

Sustar, A., Strand, L., Zimmerman, S., and Berg, C. 2023. Imaginal disk growth factors are Drosophila Chitinase-like Proteins with roles in morphogenesis and CO2 response. Genetics 223: iyac185. https://doi.org/10.1093/genetics/iyac185  PMCID: PMC9910413

O’Hanlon*, K. N., Dam*, R. A., Archambeault, S. L., and Berg, C. A. 2018. Two Drosophilids exhibit distinct EGF pathway patterns in oogenesis.  Development, Genes and Evolution 228: 31 – 48.  * co-first authors.  https://doi.org/10.1007/s00427-017-0601-8  PMCID: PMC5805658 

Zimmerman, S. G., Merrihew, G. E., MacCoss, M. J., and Berg, C. A. 2017.  Proteomics analysis identifies orthologs of human chitinase-like proteins as inducers of tube morphogenesis defects in Drosophila melanogaster.  Genetics 206: 973–984. Highlighted Article.  https://doi.org/10.1534/genetics.116.199323  PMCID: PMC5499198 

Osterfield, M., Berg, C. A., and Shvartsman, S. Y. 2017. Epithelial patterning, morphogenesis, and evolution: Drosophila eggshell as a model. Developmental Cell 41: 337 – 348. https://doi.org/10.1016/j.devcel.2017.02.018  PMCID: PMC5443119 

Peters, N. C., and Berg, C. A. 2016. In vitro culturing and live imaging of Drosophila egg chambers: A history and adaptable method. In Oogenesis; Ioannis P. Nezis, ed. Methods in Molecular Biology (Clifton, N.J.) 1457: 35-68. Cover.  http://dx.doi.org/10.1007/978-1-4939-3795-0_4 PMCID: PMC5244582. 

Zimmerman, S. G., Peters, N. C., Altaras, A. E., and Berg, C. A. 2013. Optimized RNA ISH, RNA FISH, and protein—RNA double labeling in Drosophila ovaries. Nature Protocols 8: 2158–2179. http://www.nature.com/nprot/journal/v8/n11/full/nprot.2013.136.html  PMCID: PMC4126239 

Breck Byers

Research:

A predominant line of research in the Byers lab concerns the integration of mitotic spindle behavior with other aspects of the yeast cell cycle. Mutations that alter the formation and regulation of spindle pole body — the organelle that plays a key role as the nucleation center for spindle microtubule assembly — lead to identifiable changes in subcellular structure. Detailed analysis of these changes by immunocytochemical and electron microscope methods reveal phenotypic characteristics that provide a framework for isolating yet other mutations affecting important components of the cell cycle mechanism. Functions of current interest include those that mediate the formation of a new spindle pole body at the beginning of the cell cycle or control separation of the newly formed spindle pole from the parental one so that the spindle can form. Other genes under study serve to maintain integrity of the mitotic spindle during the anaphase movements. Key methods include cloning of the relevant genes, sequencing and deletion analysis, and creation of immunological tools (such as epitope-tagged alleles) for cytological studies.

Other research in the lab focuses on the mechanisms that mediate synapsis and recombination between homologous yeast chromosomes in prophase of meiosis. The protein encoded by the HOP1 (for homologue pairing) gene has been found to play a crucial role in assembly of the synaptonemal complex, an organelle that is highly conserved among eukaryotes. Other genes of interest coordinate the complex array of meiotic functions, some of them acting as “checkpoints’ to ensure appropriate rates of progression through successive stages of the overall process.

Selected Publications:

McDonald HB and Breck Byers. 1997. A proteasome cap subunit required for spindle pole body duplication in yeast. J Cell Biol 137:539-553.

Kironmai KM, Muniyappa K, Friedman DB, Hollingsworth NM, and Breck Byers. 1998. DNA-binding activities of Hop1 protein, a synaptonemal complex component of Saccharomyces cerevisiae. Mol Cell Biol 18:1424-1435.

Dirick L, Goetsch L, Ammerer G, and Breck Byers. 1998. Regulation of meiotic S phase by Ime2 and a Clb5,6-associated kinase in Saccharomyces cerevisiae. Science 281:1854-1857.

Mathias N,  Johnson S,  Breck Byers,  Goebl M.  Mar. 1999.  The abundance of cell cycle regulatory protein Cdc4p is controlled by interactions between its f box and Skp1p.  Mol.Cell Biol.   19(3):1759-67

Munoz-Centeno MC,  McBratney S,  Monterrosa A,  Breck Byers,  Mann C,  Winey M.  July 1999.  Saccharomyces cerevisiae MPS2 encodes a membrane protein localized at the spindle pole body and the nuclear envelope.  Mol Biol Cell. 10(7):2393-406.

Muniyappa, K., S. Anuradha, and Breck Byers. 2000. Yeast meiosis-specific protein Hop1 binds to G4 DNA and promotes its formation. Mol. Cell. Biol. 20: 1361-1369.

Comai, L., A.P. Tyagi, K. Winter, R. Holmes-Davis, S.H. Reynolds, Y. Stevens, and B. Byers. 2000. Phenotypic instability and rapid gene silencing in newly formed Arabidopsis allotetraploids. The Plant Cell. 12: 1551-1567.

Zheng, C.-J., S.-W. Guo, and B. Byers. 2000. Modeling the maternal-age dependency of reproductive failure and genetic fitness. Evolution and Development. 2: 203-207

additional publication listings available via PubMed

Walton Fangman

Research:

Walt Fangman retired at the end of 2004. The laboratory continues the research under Bonita J. Brewer.

Selected Publications:

Raghuraman, M.K., Winzeler, E.A., Collingwood, D., Hunt, S., Wodicka, L., Conway, A., Lockhart, D.J., Davis, R.W., Brewer, B.J., Fangman, W.L.. Replication dynamics of the yeast genome. Science. 294: 115-121, 05 Oct 2001

van Brabant A.J., Buchanan C.D., Charboneau E., Fangman W.L., Brewer B.J. An origin-deficient yeast artificial chromosome triggers a cell cycle checkpoint. Molecular Cell. 7(4): 705-13, Apr 2001

Ward T.R., Hoang M.L., Prusty R., Lau C.K., Keil R.L., Fangman W.L., Brewer B.J. Ribosomal DNA replication fork barrier and HOT1 recombination hot spot: shared sequences but independent activities. Molecular and Cellular Biology. 20(13): 4948-57, Jul 2000

van Brabant A.J., Fangman W.L., Brewer B.J. Active role of a human genomic insert in replication of a yeast artificial chromosome.. Mol Cell Biol. 19(6): 4231-40, Jun 1999

Donaldson A.D., Raghuraman M.K., Friedman K.L., Cross F.R., Brewer B. J., Fangman W. L. CLB5-dependent activation of late replication origins in S. cerevisiae.. Mol Cell. 2(2): 173-82, Aug 1998

additional publication listings available via PubMed

Joe Felsenstein

Research:

We have lately been working on methods for estimating population parameters (such as effective population size, mutation rate, and so on) from population samples of molecular sequences. The genes at one locus in a population are related by a “gene tree” that depicts which ones are descended from recent common ancestors.

We have been using a computationally intensive method known as Markov Chain Monte Carlo Integration to make approximate calculations of the statistical likelihoods for different values of the population parameters. We are now distributing a free package of computer programs, LAMARC, to do these calculations. We think that these methods will become the standard way of analyzing population samples of sequences. My colleagues in this work have been Mary Kuhner, Jon Yamato, and Peter Beerli.

I have also been working lately on models and inference methods for quantitative characters varying between species and within-species, allowing us to infer correlated evolution of different characters. One important case is discrete 0/1 phenotypes, which can be caused by an underlying polygenic quantitative character. Years ago Sewall Wright made such a model, called the threshold model. I have adapted this to inference of covariation between characters in their evolution, by assuming that the underlying characters evolve in a correlated fashion, but that the 0/1 characters just show which of the underlying characters exceed the threshold that separates the two states. Making inferences about the covariation requires Markov chain Monte Carlo methods. I have also been working on inferring whether characters measured in different populations of a single species are under natural selection which is affected by some measured environments. There the problem is to correct for the similarities of populations that are connected by gene flow.

Selected Publications:

2002. Felsenstein, J. Quantitative characters, phylogenies, and morphometrics. pp. 27-44 in “Morphology, Shape, and Phylogenetics”, ed. N. MacLeod. Systematics Association Special Volume Series 64. Taylor and Francis, London.

2002. Felsenstein, J. Contrasts for a within-species comparative method. pp. 118-129 in “Modern Developments in Theoretical Population Genetics”, ed. M. Slatkin and M. Veuille. Oxford University Press, Oxford.

2004.  Felsenstein, J. Inferring Phylogenies. Sinauer Associates, Sunderland, Massachusetts.

2005. Felsenstein, J. Using the quantitative genetic threshold model for inferences between and within species. Philosophical Transactions of the Royal Society of London, series B 360: 1427-1434.

2006. Accuracy of coalescent likelihood estimates: Do we need more sites, more sequences, or more loci? Molecular Biology and Evolution 23: 691-700.

2007. Trees of genes in populations. pp. 3-29 in Reconstructing Evolution. New Mathematical and Computational Advances, ed. O. Gascuel and M. Steel. Clarendon Press, Oxford.

2007. Has natural selection been refuted? The arguments of William Dembski. Reports of the National Center for Science Education 27 (3-4): 20-26.

2008. Comparative methods with sampling error and within-species variation: contrasts revisited and revised. American Naturalist 171: 713-725.

2008. (A. RoyChoudhury, J. Felsenstein, and E. A. Thompson). A two-stage pruning algorithm for likelihood computation for a population tree. Genetics
180: 1095-1105.

Stanley Fields

Research:

The major focus of the Fields laboratory has been the development and implementation of new technologies. Our motivation is that a novel technology can catalyze research across a spectrum of biological investigations, often leading to multiple applications beyond those initially envisioned. Technology development has led us to experimental questions that we had previously not explored, stimulated collaborations with computational biologists, biochemists and structural biologists, and provided opportunities to contribute to findings in medicine, as through studies of cancer-associated proteins, polyglutamine aggregation, aging, Toll-like receptors and malaria. Much of our research has centered on methods of protein analysis, although we have also put effort into methodologies to analyze DNA and RNA, to further synthetic biology approaches and to explore the engineering of bacteriophages.

For many of our technology efforts, we use the unicellular eukaryote Saccharomyces cerevisiae (baker’s yeast) as the host organism for carrying out assays, but we also exploit E. coli, plant cells and tissue culture. Our philosophy on technology development is to pursue projects that can address important questions in basic biology or medicine and that can be readily applied by other labs. Recent projects have included the use of deep mutational scanning to analyze protein activities; the development of biosensors in bacteria and yeast; the identification of dominant negative mutants as reagents to inhibit protein function; and the use of mutant tRNAs to mistranslate proteins for genotype-phenotype studies.

Selected Publications:

Gamble, C.E., Brule, C.E., Dean, K.M., Fields, S. and Grayhack, E.J. (2016) Adjacent codons act in concert to modulate translation efficiency in yeast. Cell 166: 679-690.

Bhagavatula, G., Rich, M.S., Young, D., Marin, M. and Fields, S. (2017) A massively parallel fluorescence assay to detect the effects of synonymous mutations on TP53 expression. Molecular Cancer Research15: 1301-1307.

Cuperus, J.T, Groves, B., Kuchina, A., Rosenberg, A.B., Jojic, N., Fields, S. and Seelig, G. (2017) Deep learning of the regulatory grammar of yeast 5’ untranslated regions from 500,000 random sequences. Genome Research 27: 2015-2024.

Starita, L.M., Islam, M.M., Banerjee, T., Adamovich, A.I., Gullinsrud, J., Fields, S., Shendure, J. and Parvin, J.D. (2018) A multiplexed homology-directed DNA repair assay reveals the impact of more than 1,000 BRCA1 missense substitution variants on protein function. American Journal of Human Genetics 103: 498-508.

Brandsen, B.M., Mattheisen, J., Noel, T. and Fields, S. (2018) A biosensor strategy for E. coli based on ligand-dependent stabilization. ACS Synthetic Biology 7; 1990-1999.

Zimmerman, S.M., Kon, Y., Hauke, A.C., Ruiz, B.Y., Fields, S. and Phizicky, E.M. (2018) Conditional accumulation of toxic tRNAs to cause amino acid misincorporation. Nucleic Acids Research, 24: 410-422.

Dorrity, M.W., Queitsch, C. and Fields, S. (2019) High-throughput identification of dominant negative polypeptides in yeast. Nature Methods 16: 413-416.

additional publication listings available via PubMed